155 related articles for article (PubMed ID: 3217823)
1. Field trial of oral cholera vaccines in Bangladesh.
Clemens JD; Harris JR; Sack DA; Chakraborty J; Ahmed F; Stanton BF; Huda N; Khan MR; Khan MU; Kay BA
Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):417-22. PubMed ID: 3217823
[No Abstract] [Full Text] [Related]
2. [The oral cholera vaccine project; the first 3 years of field work in Bangladesh].
van Loon FP
Ned Tijdschr Geneeskd; 1991 Jan; 135(3):87-9. PubMed ID: 1996165
[No Abstract] [Full Text] [Related]
3. Oral vaccines for cholera control.
Chaturvedi S; Chaturvedi S
Natl Med J India; 1997; 10(1):17-8. PubMed ID: 9069701
[TBL] [Abstract][Full Text] [Related]
4. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
5. Questionable merits of the field trial of an oral killed whole cell cholera vaccine in Vietnam during 1998-2003.
Kabir S
Vaccine; 2007 Feb; 25(8):1353-4. PubMed ID: 17049687
[No Abstract] [Full Text] [Related]
6. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up.
Clemens JD; Sack DA; Harris JR; Van Loon F; Chakraborty J; Ahmed F; Rao MR; Khan MR; Yunus M; Huda N
Lancet; 1990 Feb; 335(8684):270-3. PubMed ID: 1967730
[TBL] [Abstract][Full Text] [Related]
7. Relationship between neighbourhood-level killed oral cholera vaccine coverage and protective efficacy: evidence for herd immunity.
Emch M; Ali M; Park JK; Yunus M; Sack DA; Clemens JD
Int J Epidemiol; 2006 Aug; 35(4):1044-50. PubMed ID: 16723370
[TBL] [Abstract][Full Text] [Related]
8. Prospects for control of cholera with oral vaccines.
Sack RB
J Diarrhoeal Dis Res; 1992 Mar; 10(1):1-3. PubMed ID: 1619235
[No Abstract] [Full Text] [Related]
9. Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh.
Sarker AR; Islam Z; Khan IA; Saha A; Chowdhury F; Khan AI; Cravioto A; Clemens JD; Qadri F; Khan JA
Vaccine; 2015 Sep; 33(38):4916-21. PubMed ID: 26232545
[TBL] [Abstract][Full Text] [Related]
10. Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding.
Ahmed T; Svennerholm AM; Al Tarique A; Sultana GN; Qadri F
Vaccine; 2009 Feb; 27(9):1433-9. PubMed ID: 19146904
[TBL] [Abstract][Full Text] [Related]
11. Herd protection and herd amplification in cholera.
Sack DA
J Health Popul Nutr; 2006 Mar; 24(1):1-5. PubMed ID: 16796143
[No Abstract] [Full Text] [Related]
12. A controlled field trial on the effectiveness of the intradermal and subcutaneous administration of cholera vaccine in the Philippines.
Philippines Cholera Committee
Bull World Health Organ; 1973; 49(4):389-94. PubMed ID: 4603994
[TBL] [Abstract][Full Text] [Related]
13. Cholera: developments in prevention and cure.
van Loon FP
Trop Geogr Med; 1993; 45(6):269-73. PubMed ID: 8116056
[TBL] [Abstract][Full Text] [Related]
14. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD
Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967
[TBL] [Abstract][Full Text] [Related]
15. Formulation in tablets of a cholera whole cells inactivated vaccine candidate.
Talavera A; Año G; Pino Y; Castaño J; Uribarri E; Riverón L; Gil S; Fernández S; Cedré B; Valmaseda T; Pérez JL; Infante JF; García L; Sierra G
Vaccine; 2006 Apr; 24(16):3381-7. PubMed ID: 16460846
[TBL] [Abstract][Full Text] [Related]
16. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam.
Vu DT; Hossain MM; Nguyen DS; Nguyen TH; Rao MR; Do GC; Naficy A; Nguyen TK; Acosta CJ; Deen JL; Clemens JD; Dang DT
J Health Popul Nutr; 2003 Dec; 21(4):304-8. PubMed ID: 15043004
[TBL] [Abstract][Full Text] [Related]
17. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.
Ali M; Emch M; von Seidlein L; Yunus M; Sack DA; Rao M; Holmgren J; Clemens JD
Lancet; 2005 Jul 2-8; 366(9479):44-9. PubMed ID: 15993232
[TBL] [Abstract][Full Text] [Related]
18. Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up.
van Loon FP; Clemens JD; Chakraborty J; Rao MR; Kay BA; Sack DA; Yunus M; Ali M; Svennerholm AM; Holmgren J
Vaccine; 1996 Feb; 14(2):162-6. PubMed ID: 8852414
[TBL] [Abstract][Full Text] [Related]
19. Efficacy calculation in randomized trials: global or local measures?
Emch M; Ali M; Acosta C; Yunus M; Sack DA; Clemens JD
Health Place; 2007 Mar; 13(1):238-48. PubMed ID: 16529974
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial.
Qadri F; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Begum YA; Bhuiyan TR; Chowdhury MI; Uddin MJ; Khan JAM; Chowdhury AI; Rahman A; Siddique SA; Asaduzzaman M; Akter A; Khan A; Ae You Y; Siddik AU; Saha NC; Kabir A; Riaz BK; Biswas SK; Begum F; Unicomb L; Luby SP; Cravioto A; Clemens JD
Lancet; 2015 Oct; 386(10001):1362-1371. PubMed ID: 26164097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
